4 COVID-19 Ds to remember when approaching Monkeypox

Shanker, Aparajeya; Tsagkaris, Christos

doi:10.1016/j.amsu.2022.104491

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To avert misconceptions regarding vaccination in influencing hesitancy, health authorities should openly approach these false claims with both cultural and religious awareness in mind [ 31 ]. Tailoring approach is needed in highly polarized communities that are exposed to divergent messaging from authorities [ 32 ] or in subgroups with distinctive behavioral or perception patterns [ 33 ].…”

Section: Discussionmentioning

confidence: 99%

Understanding vaccine hesitancy with PCV13 in children: Results of a survey in Shanghai, China

Ni¹,

Xu²,

Wang³

2023

PLoS ONE

View full text Add to dashboard Cite

A questionnaire survey for parents of children under 5 years of age was conducted to analyze vaccine hesitancy with the 13-valent pneumococcal conjugate vaccine (PCV13) in Shanghai, China. A total of 892 valid questionnaires were collected. Descriptive statistical methods, Chi-square test and effect size of Cohen were used. Among participants, 421 (48.8%) had children who had been vaccinated with PCV13 before the survey while 227 (26.73%) planned vaccination with PCV13 in the future. The main reasons for not receiving vaccination were the fear of adverse reactions (79, 26.7%), beyond vaccination age (69, 23.3%), and no need to vaccinate (44, 14.9%). Reducing vaccine hesitancy and increasing vaccination willingness can be achieved through health interventions, lower vaccine prices, and the adjustment of vaccination strategies.

show abstract

Section: Discussionmentioning

confidence: 99%